SUBSCRIBERS

As biotech selling spreads, more weakness is seen for US health stocks

Published Sun, Oct 25, 2015 · 09:50 PM

    DeeperDive is a beta AI feature. Refer to full articles for the facts.

    New York

    AFTER a four-year love affair with healthcare shares, investors are moving on.

    Selling has spread from biotechs - shaken on Sept 21 when Hillary Clinton first tweeted concerns about drug prices - to other areas of the healthcare sector. Investors have been dumping shares of everything from hospitals to traditional pharmaceutical companies and insurers in recent weeks.

    Share with us your feedback on BT's products and services